메뉴 건너뛰기




Volumn 43, Issue 2, 2000, Pages 254-258

Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: A comment to the debate on randomized controlled trials

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHLORPROPAMIDE; GLIBENCLAMIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

EID: 0033994539     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050039     Document Type: Review
Times cited : (17)

References (48)
  • 1
    • 0001411042 scopus 로고
    • The historical development of clinical therapeutic trials
    • 1. Bull JP (1959) The historical development of clinical therapeutic trials. J Chron Dis 10: 218-248
    • (1959) J Chron Dis , vol.10 , pp. 218-248
    • Bull, J.P.1
  • 2
    • 0001392180 scopus 로고
    • The clinical trial
    • 2. Bradford Hill A (1952) The clinical trial. New Engl J Med 247: 113-119
    • (1952) New Engl J Med , vol.247 , pp. 113-119
    • Bradford Hill, A.1
  • 4
    • 0002883755 scopus 로고
    • How members of the Cochrane Collaboration prepare and maintain systematic reviews of the effects of health care
    • 4. Fullerton-Smith I (1995) How members of the Cochrane Collaboration prepare and maintain systematic reviews of the effects of health care. Evidence-Based medicine 1: 7-8
    • (1995) Evidence-based Medicine , vol.1 , pp. 7-8
    • Fullerton-Smith, I.1
  • 7
    • 84920245150 scopus 로고
    • WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: Final mortality follow-up
    • 7. Committee of Principal Investigators (1984) WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet II: 600-604
    • (1984) Lancet , vol.2 , pp. 600-604
  • 8
    • 0025374223 scopus 로고
    • Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
    • 8. Riggs BL, Hidgson SF, O'Fallon WM et al. (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. New Engl J Med 322: 802-809
    • (1990) New Engl J Med , vol.322 , pp. 802-809
    • Riggs, B.L.1    Hidgson, S.F.2    O'Fallon, W.M.3
  • 9
    • 0031841439 scopus 로고    scopus 로고
    • Chemoprevention of lung cancer: The rise and demise of beta-carotene
    • 9. Onmen GS (1998) Chemoprevention of lung cancer: the rise and demise of beta-carotene. Ann Rev Public Health 19: 73-99
    • (1998) Ann Rev Public Health , vol.19 , pp. 73-99
    • Onmen, G.S.1
  • 10
    • 0027487181 scopus 로고
    • Mortality following ventricular arrhythmia suppression with encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the cardiac arrhythmia suppression trial
    • 10. Epstein AE, Hallstrom AP, Rogers WJ (1993) Mortality following ventricular arrhythmia suppression with encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the cardiac arrhythmia suppression trial. JAMA 270: 2451-2455
    • (1993) JAMA , vol.270 , pp. 2451-2455
    • Epstein, A.E.1    Hallstrom, A.P.2    Rogers, W.J.3
  • 11
    • 0032585188 scopus 로고    scopus 로고
    • The unpredictability paradox: Review of empirical comparisons of randomized and non-randomized clinical trials
    • 11. Kunz R, Oxman AD (1998) The unpredictability paradox: review of empirical comparisons of randomized and non-randomized clinical trials. BMJ 317: 1185-1190
    • (1998) BMJ , vol.317 , pp. 1185-1190
    • Kunz, R.1    Oxman, A.D.2
  • 12
    • 0029896903 scopus 로고    scopus 로고
    • To bridge science and patient care in diabetes
    • 12. Berger M (1996) To bridge science and patient care in diabetes. Diabetologia 39: 749-757
    • (1996) Diabetologia , vol.39 , pp. 749-757
    • Berger, M.1
  • 13
    • 0003189775 scopus 로고
    • Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes, VIII
    • 13. The University Group Diabetes Program (1982) Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes, VIII. Diabetes 31 [Suppl 5]: S1-S81
    • (1982) Diabetes , vol.31 , Issue.SUPPL. 5
  • 14
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33)
    • 14. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 352: 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 15
    • 0018225976 scopus 로고
    • Diabetes mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973
    • 15. Pirart J (1977) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168-188, 252-261
    • (1977) Diabetes Care , vol.1 , pp. 168-188
    • Pirart, J.1
  • 16
    • 0027370108 scopus 로고
    • The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • 16. The Diabetes Control and Complications Trial (1993) The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977-986
    • (1993) New Engl J Med , vol.329 , pp. 977-986
    • Control, T.D.1    Trial, C.2
  • 17
    • 0030065635 scopus 로고    scopus 로고
    • Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus
    • 17. Colwell JA, Clark CM (1996) Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Int Med 124: 178-179
    • (1996) Ann Int Med , vol.124 , pp. 178-179
    • Colwell, J.A.1    Clark, C.M.2
  • 18
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • 18. UK Prospective Diabetes Study (UKPDS) Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713
    • (1998) BMJ , vol.317 , pp. 703-713
  • 19
    • 0000559926 scopus 로고
    • A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes mellitus, II. Mortality results
    • 19. University Group Diabetes Program (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes mellitus, II. Mortality results. Diabetes 10 [Suppl 2]: S785-S830
    • (1970) Diabetes , vol.10 , Issue.SUPPL. 2
  • 20
    • 0031985020 scopus 로고    scopus 로고
    • Standards of medical care for patients with diabetes mellitus
    • 20. American Diabetes Association (1998) Standards of medical care for patients with diabetes mellitus. Diabetes Care 21 [Suppl 1] S23-S31
    • (1998) Diabetes Care , vol.21 , Issue.SUPPL. 1
  • 21
    • 0031752050 scopus 로고    scopus 로고
    • Implications for the pharmacotherapy of Type 2 diabetes mellitus
    • The United Kingdom Prospective Diabetes Study (UKPDS)
    • 21. Bretzel RG, Voigt Kh, Schatz H (1998) The United Kingdom Prospective Diabetes Study (UKPDS). Implications for the pharmacotherapy of Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 106: 369-372
    • (1998) Exp Clin Endocrinol Diabetes , vol.106 , pp. 369-372
    • Bretzel, R.G.1    Voigt, K.2    Schatz, H.3
  • 22
    • 0001344281 scopus 로고    scopus 로고
    • A desktop guide to Type 2 non-insulin-dependent diabetes mellitus
    • 22. Home PD, Alberti KGMM for the European NIDDM Policy Group (1999) A desktop guide to Type 2 non-insulin-dependent) diabetes mellitus. Diabet Med 16: 716-750
    • (1999) Diabet Med , vol.16 , pp. 716-750
    • Home, P.D.1    Alberti, K.G.M.M.2
  • 23
    • 0033517525 scopus 로고    scopus 로고
    • Are drugs within a class interchangeable?
    • 23. Furberg CD, Herrington DM, Psaty BM (1999) Are drugs within a class interchangeable? Lancet 354: 1202-1204
    • (1999) Lancet , vol.354 , pp. 1202-1204
    • Furberg, C.D.1    Herrington, D.M.2    Psaty, B.M.3
  • 24
    • 0025833955 scopus 로고
    • Study design, progress and performance (UKPDS VIII)
    • 24. UK Prospective Diabetes Study (UKPDS) Group (1991) Study design, progress and performance (UKPDS VIII). Diabetologia 34: 877-890
    • (1991) Diabetologia , vol.34 , pp. 877-890
  • 25
    • 0029916829 scopus 로고    scopus 로고
    • Sulfonylurea treatment of NIDDM patients with cardiovascular disease: A mixed blessing
    • 25. Leibowitz G, Cerasi E (1996) Sulfonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing. Diabetologia 39: 503-514
    • (1996) Diabetologia , vol.39 , pp. 503-514
    • Leibowitz, G.1    Cerasi, E.2
  • 27
    • 0013619925 scopus 로고    scopus 로고
    • Sulfonylureas and ischaemic preconditioning
    • 27. Klepzig H, Kobert G, Matter C, Luus H et al. (1999) Sulfonylureas and ischaemic preconditioning. Eur Heart J 20: 839-846
    • (1999) Eur Heart J , vol.20 , pp. 839-846
    • Klepzig, H.1    Kobert, G.2    Matter, C.3    Luus, H.4
  • 28
    • 0030974812 scopus 로고    scopus 로고
    • Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
    • 28. Malmberg K for the DIGAMI Study Group (1997) Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314: 1512-1515
    • (1997) BMJ , vol.314 , pp. 1512-1515
  • 29
    • 0033614537 scopus 로고    scopus 로고
    • The UKPDS: What was the question?
    • 29. Ewart RM (1999) The UKPDS: what was the question? Lancet 353: 1882
    • (1999) Lancet , vol.353 , pp. 1882
    • Ewart, R.M.1
  • 30
    • 0033514067 scopus 로고    scopus 로고
    • Could institutional clinical trials exist in Europe?
    • 30. Cornu C, Cano A, Pornel B Mellis GB, Boissel JP on behalf of the EUTERP Pilot Study Group (1999) Could institutional clinical trials exist in Europe? Lancet 353: 63-64
    • (1999) Lancet , vol.353 , pp. 63-64
    • Cornu, C.1    Cano, A.2    Pornel, B.3    Mellis, G.B.4    Boissel, J.P.5
  • 31
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • 31. Hulley S, Grady D, Bush T et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613
    • (1998) JAMA , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 32
    • 0013633602 scopus 로고    scopus 로고
    • Are randomized controlled trials sufficient evidence to guide clinical practice in Type II diabetes mellitus?
    • in press
    • 32. Vijan S, Kent DM, Hayward RA (1999) Are randomized controlled trials sufficient evidence to guide clinical practice in Type II diabetes mellitus? Diabetologia (in press)
    • (1999) Diabetologia
    • Vijan, S.1    Kent, D.M.2    Hayward, R.A.3
  • 33
    • 0032492394 scopus 로고    scopus 로고
    • Treatment of hypertensive patients with diabetes
    • 33. Pahor M, Psaty BM, Furberg CD (1998) Treatment of hypertensive patients with diabetes. Lancet 351: 689-690
    • (1998) Lancet , vol.351 , pp. 689-690
    • Pahor, M.1    Psaty, B.M.2    Furberg, C.D.3
  • 34
    • 0033032552 scopus 로고    scopus 로고
    • Prognosis and treatment of cardiovascular disease in diabetes mellitus
    • 34. Sawicki PT, Berger M (1999) Prognosis and treatment of cardiovascular disease in diabetes mellitus. J Clin Basic Cardiol 2: 22-33
    • (1999) J Clin Basic Cardiol , vol.2 , pp. 22-33
    • Sawicki, P.T.1    Berger, M.2
  • 35
    • 0025425570 scopus 로고
    • Diabetes care and research in Europe: The St. Vincent declaration
    • 35. WHO/IDF Europe (1990) Diabetes care and research in Europe: The St. Vincent Declaration. Diabet Med 7: 360
    • (1990) Diabet Med , vol.7 , pp. 360
  • 36
    • 0033053251 scopus 로고    scopus 로고
    • Can data-driven benchmarks be used to set the goals of healthy people 2010?
    • 36. Allison J, Kiefe CJ, Weissmann NW (1999) Can data-driven benchmarks be used to set the goals of healthy people 2010? Am J Publ Health 89: 61-65
    • (1999) Am J Publ Health , vol.89 , pp. 61-65
    • Allison, J.1    Kiefe, C.J.2    Weissmann, N.W.3
  • 37
    • 0344629352 scopus 로고    scopus 로고
    • Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality circle experience in Germany
    • 37. Müller UA, Femerling M, Reinauer KM et al. for the ASD Working Group (1999) Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality circle experience in Germany. Diabetes Care 22 [Suppl 2]: 829-834
    • (1999) Diabetes Care , vol.22 , Issue.SUPPL. 2 , pp. 829-834
    • Müller, U.A.1    Femerling, M.2    Reinauer, K.M.3
  • 38
    • 0030662005 scopus 로고    scopus 로고
    • Estimated benefits of glycemic control in microvascular complications in Type 2 diabetes
    • 38. Vijan S, Hofer TP, Hayward RA (1997) Estimated benefits of glycemic control in microvascular complications in Type 2 diabetes. Ann Intern Med 127: 788-795
    • (1997) Ann Intern Med , vol.127 , pp. 788-795
    • Vijan, S.1    Hofer, T.P.2    Hayward, R.A.3
  • 39
    • 15644366137 scopus 로고    scopus 로고
    • Model of complications of NIDDM. II. Analysis of health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
    • 39. Eastman RC, Javitt JC, Herman WH et al. (1997) Model of complications of NIDDM. II. Analysis of health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20: 735-744
    • (1997) Diabetes Care , vol.20 , pp. 735-744
    • Eastman, R.C.1    Javitt, J.C.2    Herman, W.H.3
  • 40
    • 0031738114 scopus 로고    scopus 로고
    • Implications of the United Kingdom Prospective Diabetes Study. Position Statement
    • 40. American Diabetes Association (1998) Implications of the United Kingdom Prospective Diabetes Study. Position Statement. Diabetes Care 21: 2180-2184
    • (1998) Diabetes Care , vol.21 , pp. 2180-2184
  • 41
    • 0029094533 scopus 로고
    • The relationship of glycemic exposure (HbAIc) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
    • 41. The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbAIc) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983
    • (1995) Diabetes , vol.44 , pp. 968-983
  • 43
    • 0345729873 scopus 로고    scopus 로고
    • Diabetes care and patient-oriented outcomes
    • 43. Berger M, Mühlhauser I (1999) Diabetes care and patient-oriented outcomes. JAMA 281: 1676-1678
    • (1999) JAMA , vol.281 , pp. 1676-1678
    • Berger, M.1    Mühlhauser, I.2
  • 44
    • 0030696063 scopus 로고    scopus 로고
    • Starting insulin therapy in patients with type 2 diabetes: Effectiveness, complications, and resource utilization
    • 44. Hayward RA, Manning WG, Kaplan SH et al. (1997) Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. J Am Med Ass 278: 1663-1669
    • (1997) J Am Med Ass , vol.278 , pp. 1663-1669
    • Hayward, R.A.1    Manning, W.G.2    Kaplan, S.H.3
  • 45
    • 0344141203 scopus 로고    scopus 로고
    • Rationale for the use of insulin therapy alone as the pharmacological treatment of Type 2 diabetes
    • 45. Berger M, Jörgens V, Mühlhauser I (1999) Rationale for the use of insulin therapy alone as the pharmacological treatment of Type 2 diabetes. Diabetes Care 22 [Suppl 3]: C71-75
    • (1999) Diabetes Care , vol.22 , Issue.SUPPL. 3
    • Berger, M.1    Jörgens, V.2    Mühlhauser, I.3
  • 46
    • 0031840684 scopus 로고    scopus 로고
    • Should insulin therapy be started on an out-or inpatient basis?
    • 46. Müller UA, Müller R, Hunger-Dathe W et al. (1998) Should insulin therapy be started on an out-or inpatient basis? Diabet Metab 24: 251-255
    • (1998) Diabet Metab , vol.24 , pp. 251-255
    • Müller, U.A.1    Müller, R.2    Hunger-Dathe, W.3
  • 47
    • 0033600435 scopus 로고    scopus 로고
    • Clinical trials, consensus conferences, and clinical practice
    • 47. Sniderman AD (1999) Clinical trials, consensus conferences, and clinical practice. Lancet 354: 327-330
    • (1999) Lancet , vol.354 , pp. 327-330
    • Sniderman, A.D.1
  • 48
    • 0033603785 scopus 로고    scopus 로고
    • Surrogate end points, health outcomes, and the drug approval process for the treatment of risk factors for cardio-vascular disease
    • 48. Psaty BM, Weiss NS, Furberg CD et al. (1999) Surrogate end points, health outcomes, and the drug approval process for the treatment of risk factors for cardio-vascular disease. JAMA 282: 786-790
    • (1999) JAMA , vol.282 , pp. 786-790
    • Psaty, B.M.1    Weiss, N.S.2    Furberg, C.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.